According to 4D Molecular Therapeutics's latest financial reports the company's current revenue (TTM) is $20.72 M. In 2022 the company made a revenue of $3.12 M a decrease over the years 2021 revenue that were of $18.03 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $20.72 M | 562.47% |
2022 | $3.12 M | -82.66% |
2021 | $18.03 M | 32.52% |
2020 | $13.61 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |